Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost Savings
Renée Hangaard Olesen, Nicholas Carlson, Jens Søndergaard, Ellen Linnea Freese Ballegaard, Rikke Borg, Lars Holger Ehlers · 2026
Read Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost Savings by Renée Hangaard Olesen, Nicholas Carlson, Jens Søndergaard, Ellen Linnea Freese Ballegaard, Rikke Borg, Lars Holger Ehlers (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218231.txt.
Description
Rationale & ObjectiveChronic kidney disease (CKD) poses an increasing global burden for patients and health care providers, driven by aging populations and the rising prevalence of chronic diseases. Despite strong evidence supporting benefits of sodium/glucose cotransporter 2 inhibitors (SGLT2is), uptake remains limited.
Catalog record
| CREATOR | Renée Hangaard Olesen, Nicholas Carlson, Jens Søndergaard, Ellen Linnea Freese Ballegaard, Rikke Borg, Lars Holger Ehlers |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |